-+ 0.00%
-+ 0.00%
-+ 0.00%

VALNEVA SE - FIRST PHASE 3 DATA READOUT FOR LYME DISEASE VACCINE CANDIDATE ANTICIPATED IN FIRST HALF OF 2026

Reuters·02/19/2026 06:00:01

Please log in to view news